49 related articles for article (PubMed ID: 35847941)
1. A clinicopathological-imaging nomogram for the prediction of pathological complete response in breast cancer cases administered neoadjuvant therapy.
Yang W; Yang Y; Zhang C; Yin Q; Zhang N
Magn Reson Imaging; 2024 May; 111():120-130. PubMed ID: 38703971
[TBL] [Abstract][Full Text] [Related]
2. Nomogram for predicting amputation-free survival in acute lower limb ischemia patients treated by endovascular therapy.
Huang H; Kong J; He X; Chen L; Su H
Heliyon; 2024 Jun; 10(11):e32110. PubMed ID: 38867944
[TBL] [Abstract][Full Text] [Related]
3. Correction for: A novel six-microRNA-based model to improve prognosis prediction of breast cancer.
Lai J; Wang H; Pan Z; Su F
Aging (Albany NY); 2024 Feb; 16(4):4074. PubMed ID: 38441535
[No Abstract] [Full Text] [Related]
4. Development and Validation of a Prognostic Nomogram for HR+ HER- Breast Cancer.
Zhou JY; Pan CG; Ye Y; Li ZW; Fu WD; Jiang BH
Cancer Manag Res; 2024; 16():491-505. PubMed ID: 38800665
[TBL] [Abstract][Full Text] [Related]
5. Relationship between telomere length and the prognosis of breast cancer based on estrogen receptor status: A Mendelian randomization study.
Li Y; Ma L
Front Oncol; 2022; 12():1024772. PubMed ID: 36338739
[TBL] [Abstract][Full Text] [Related]
6. A Novel Prognostic Nomogram for Predicting Survival of Hormone Receptor-Positive and HER2 Negative Advanced Breast Cancer Among the Han-Population.
Zhu Y; Wang J; Xu B
Front Oncol; 2022; 12():918759. PubMed ID: 35847941
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a nomogram for predicting survival of advanced breast cancer patients in China.
Lin S; Mo H; Li Y; Guan X; Chen Y; Wang Z; Yuan P; Wang J; Luo Y; Fan Y; Cai R; Li Q; Chen S; Zhang P; Li Q; Ma F; Xu B
Breast; 2020 Oct; 53():172-180. PubMed ID: 32836201
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a nomogram for predicting survival of breast cancer patients with ipsilateral supraclavicular lymph node metastasis.
Lyu MH; Ma YZ; Tian PQ; Guo HH; Wang C; Liu ZZ; Chen XC
Chin Med J (Engl); 2021 Nov; 134(22):2692-2699. PubMed ID: 34743149
[TBL] [Abstract][Full Text] [Related]
9. Establishment of Prognostic Nomograms for Predicting the Survival of HR-Positive, HER2-Negative Metastatic Breast Cancer Patients Treated with Everolimus.
Duan F; Song C; Ma Y; Jiang K; Xu F; Bi X; Huang J; Hong R; Huang Z; Lu Q; Yuan Z; Wang S; Xia W
Drug Des Devel Ther; 2021; 15():3463-3473. PubMed ID: 34408400
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a nomogram in survival prediction among advanced breast cancer patients.
Zhao J; Yang Y; Pang D; Yu Y; Lin X; Chen K; Ye G; Tang J; Hu Q; Chai J; Bi Z; Ding L; Wu W; Zeng Y; Gui X; Liu D; Yao H; Wang Y
Ann Transl Med; 2020 Nov; 8(21):1446. PubMed ID: 33313191
[TBL] [Abstract][Full Text] [Related]
11. Clinical features of patients with HER2-positive breast cancer and development of a nomogram for predicting survival.
Fan Y; Wang Y; He L; Imani S; Wen Q
ESMO Open; 2021 Aug; 6(4):100232. PubMed ID: 34392135
[TBL] [Abstract][Full Text] [Related]
12. Construction and validation of prognostic nomogram for metaplastic breast cancer.
Li Y; Chen D; Xuan H; Dragomir MP; Calin GA; Meng X; Chen M; Jin H
Bosn J Basic Med Sci; 2022 Feb; 22(1):131-139. PubMed ID: 34247567
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
